• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION AUTOGEN; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION AUTOGEN; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D Back to Search Results
Model Number G179
Device Problems High impedance (1291); Failure to Read Input Signal (1581); Failure to Select Signal (1582)
Patient Problems No Known Impact Or Consequence To Patient (2692); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/01/2019
Event Type  malfunction  
Manufacturer Narrative
The device and lead remain implanted and in service.As no further information concerning this report is expected, our investigation is complete.This investigation will be updated should further information be provided.
 
Event Description
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) and associated right ventricular (rv) lead exhibited high, out-of-range (oor) shock impedance measurements.An alert was generated in the remote monitoring system.No electrograms showed noise on the rv lead.Technical services reviewed the available data and confirmed one oor measurement had occurred in (b)(6) 2019, with normal measurements of 85-95 ohms observed until this new spike of 131 ohms.Technical services recommended bringing the patient into the clinic for troubleshooting, including provocative maneuvers to attempt to create noise on the lead.If no noise could be produced, they could continue monitoring the shock impedance in the remote monitoring system, and could adjust the shock impedance limit in the device to 150 ohms to avoid new alerts for this issue.No adverse patient effects were reported.
 
Manufacturer Narrative
The device and lead remain implanted and in service.As no further information concerning this report is expected, our investigation is complete.This investigation will be updated should further information be provided.
 
Event Description
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) and associated right ventricular (rv) lead exhibited high, out-of-range (oor) shock impedance measurements.An alert was generated in the remote monitoring system.No electrograms showed noise on the rv lead.Technical services reviewed the available data and confirmed one oor measurement had occurred in february 2019, with normal measurements of 85-95 ohms observed until this new spike of 131 ohms.Technical services recommended bringing the patient into the clinic for troubleshooting, including provocative maneuvers to attempt to create noise on the lead.If no noise could be produced, they could continue monitoring the shock impedance in the remote monitoring system, and could adjust the shock impedance limit in the device to 150 ohms to avoid new alerts for this issue.No adverse patient effects were reported.Additional information was received.In the patient's remote interrogation in june 2024 a new alert was recorded for a high, out-of-range shock impedance measurement of 154 ohms.A request was made for technical services to review the device data and provide a recommendation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AUTOGEN
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key9208252
MDR Text Key165609174
Report Number2124215-2019-21584
Device Sequence Number1
Product Code NIK
Combination Product (y/n)N
Reporter Country CodeAS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/28/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date01/18/2019
Device Model NumberG179
Device Catalogue NumberG179
Device Lot Number163664
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/03/2019
Initial Date FDA Received10/18/2019
Supplement Dates Manufacturer Received06/03/2024
Supplement Dates FDA Received06/28/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/16/2017
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Age76 YR
-
-